logo
Select company
Select metric
-0.7%Buyback Yield
VS
Market
28
Sector
56
Industry
69
History
73
$ 2.97Close
$ 0.51 - $ 5.18 52-Week Range
Ticker Information

Ticker

PROK

Company Name

PROKIDNEY CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

PROKIDNEY CORP - Buyback Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

PROK - Buyback Yield Historical data
DateBuyback YieldMarket CapitalizationNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025-0.7%$ 659.19M$ 4.61M
3/31/2025-65.81%$ 219.53M$ 144.46M
12/31/2024-47.46%$ 304.41M$ 144.46M
9/30/2024-22.55%$ 597.91M$ 134.83M
6/30/2024-20.64%$ 631.49M$ 130.36M
3/31/20241.46%$ 651.07M$ -9.5M
12/31/20232.96%$ 321.08M$ -9.5M
9/30/20230%$ 357.86M$ 0
6/30/2023-18.33%$ 2.99B$ 548.55M
3/31/2023-25.6%$ 2.12B$ 543M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • PROKIDNEY CORP's latest trailing twelve months (TTM) Buyback Yield stands at 0%.
  • Over the past 5 years, PROKIDNEY CORP's average Buyback Yield has been -24.66%.
  • The median Buyback Yield for PROKIDNEY CORP during this period was -20.03%
  • PROKIDNEY CORP reached its highest Buyback Yield over the past 5 years at 2.96%.
  • The lowest Buyback Yield recorded by PROKIDNEY CORP in the same timeframe -79.82%

PROKIDNEY CORP's Buyback Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Buyback Yield Benchmarks
CompanyBuyback Yield
SEPN : SEPTERNA INC -59.19%MREO : MEREO BIOPHARMA GROUP PLC 0.13%ABEO : ABEONA THERAPEUTICS INC -6.01%CRDF : CARDIFF ONCOLOGY INC -23.44%AVTX : AVALO THERAPEUTICS INC -63.27%BBOT : BRIDGEBIO ONCOLOGY THERAPEUTICS INC 29.36%COYA : COYA THERAPEUTICS INC -9.42%MNMD : MIND MEDICINE (MINDMED) INC -10.89%SANA : SANA BIOTECHNOLOGY INC -0.62%ERNA : ERNEXA THERAPEUTICS INC -47.43%

Definition of Buyback Yield

[Calculation] The Buyback Yield is a ratio that calculates the difference between the trailing twelve-month share issuances and repurchases [NCFCommon] and divides it by the [MarketCap] of the company. A negative value indicates a dilution of shareholder value and might be considered as a warning sign.
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for PROKIDNEY CORP is calculated as follows: (-1 * CF - Equity [ $ 0 ]) / Market Cap [ $ 314.86M ]
(=) Buyback Yield [ 0% ]

PROK - Buyback Yield, Last 5 years

-79.82%

Minimum

Dec 31, 2021

2.96%

Maximum

Dec 31, 2023

-24.66%

Average

-20.03%

Median

Buyback Yield Benchmark Analysis

The chart above depicts the distribution of Buyback Yield for companies in the Total Stock Market. The average Buyback Yield of the companies is 0.64% with a standard deviation of 2.7%.
The following table provides additional summary stats:
Buyback Yield in the Market:
filtered constituents3.28K
min-8.43%
max8.43%
average0.64%
median0.01%
std2.7%